EquityFlow
›
Companies
› Tozaro
Tozaro
Biotech
· GB
Piattaforma che riduce i costi di produzione dei vettori virali per le terapie geniche.
Funding history
Date
Round
Amount
Feb 2026
Funding round
UK-based Tozaro raised £6 million led by Mercia Ventures to slash gene therapy manufacturing costs.
$8.2M
Investors
Mercia Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →